Global Pharmaceutical Grade Methyl Isonicotinate market was valued at USD 24.8 million in 2024 and is projected to reach USD 62.3 million by 2032, exhibiting a robust CAGR of 12.2% during the forecast period. Pharmaceutical Grade Methyl Isonicotinate, a high-purity ester derivative of isonicotinic acid, has transitioned from a specialized chemical intermediate to a critical active...